Cefprozil versus cefuroxime axetil in the treatment of acute sinusitis

Clinical Drug Investigation

Volumn 15, Issue 2, 1998, Pages 81-90

  Brankston, E R ^a   Conter, H S ^b   Corriveau, R ^c   Martel, J M ^c   Laroche, C ^d   Roy, R ^e   Savard, C ^f   Roy, D ^g   Kelly, R ^h   Forget, P ⁱ   Rivard, M ^j   Boulerice, F ^k  

^a Oshawa Clinic   (Canada)

^b Gladstone Professional Centre   (Canada)

^c Clinique Médicale Cadillac ^*

^d Clinique Médicale Cadillac   (Canada)

^e Parkdale Clinic   (Canada)

^f CLSC Verdun   (Canada)

^g NOTRE DAME HOSPITAL   (Canada)

^h CLSC Verdun   (Canada)

ⁱ Notre Dame Hospital   (Canada)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k BRISTOL MYERS SQUIBB   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFPROZIL; CEFUROXIME AXETIL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GENERAL PRACTICE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SOMNOLENCE; TASTE DISORDER; UROGENITAL TRACT INFECTION; VAGINITIS; VERTIGO; VOMITING;

EID: 15444344666     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199815020-00002     Document Type: Article

References (47)

1. Williams Jr JW, Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA 1993; 270: 1242-6
2. Evans Jr FO, Sydnor JB, Moore WEC, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975; 293: 735-9
3. Hamory BH, Sande MA, Sydnor Jr A, et al. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979; 139: 197-202
4. Gwaltney Jr JM, Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457-62
5. Norrby SR. Clinical aspects on upper respiratory tract infections. Scand J Infect Dis 1983; Suppl. 39: 14-8
6. Mardh PA, Hovelius B, Nordenfeldt E, et al. The incidence of aetiology of respiratory tract infections in general practice - with emphasis on Mycoplasma pneumonia. Infection 1976; 4 Suppl. 1: 40
7. Royal College of General Practitioners. Office of population consensus. Department of Health and Social Security. Morbidity statistics from general practice 1981-82. HMSO, London 1986
8. van Duijn NP, Brouwer HJ, Lamberts H. Use of symptoms and signs to diagnose maxillary sinusitis in general practice. Comparison with ultrasonography. BMJ 1992; 305: 684
9. Gwaltney Jr JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-25
10. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. Can Med Assoc J 1997; 156 (6 Suppl.): S1-S14
11. Reuler JB, Lucas LM, Kumar KL. Sinusitis. A review for generalists. West J Med 1995; 163: 40-8
12. Levine HL. Acute sinusitis: impact and management. Cleve Clin J Med 1991; 58: 296-7
13. Gwaltney Jr JM, Sydnor Jr A, Sande MA. Etiology and antimicrobial treatment of acute sinusitis in adults. Ann Otol Rhinol Laryngol 1981; 90: 68-71
14. Eliasson I, Kamne C, Prellner K. Beta-lactamase production in the upper respiratory tract flora. Eur J Clin Microbiol 1986; 5: 507-12
15. Ahmad F, McLeod DT, Croughan MJ, et al. Antimicrobial susceptibility of Branhamella catarrhalis respiratory infections. Antimicrob Agents Chemother 1984; 26: 424-5
16. Alverez S, Jones M, Holstsclaw-Berk S, et al. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother 1985; 27: 646-7
17. Barry AL, Pfaller MA, Fuchs PC, et al. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994; 38: 2419-25
18. Gwaltney Jr JM. Microbiology of sinusitis. In: Druce HM, editor. Sinusitis: Pathophysiology and treatment. New York: Marcel Dekker, 1994: 41-56
19. Thornsberry C, Brown SD, Yee YC, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the US. Effect on susceptibility to oral cephalosporins. Infect Med 1993; 10 Suppl. D: 15-24
20. Simor AE, Rachlis A, Art LL, et al. Emergence of penicillin-resistant Streptococcus pneumoniae in southern Ontario. Can J Infect Dis 1995; 6: 157-60
21. Simor AE, Louie M, The Canadian Bacterial Surveillance Network, et al. Canadian National Survey of Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2190-3
22. Ramsey PG, Wymuller EA. Complications of bacterial infection of the ears, paranasal sinuses, and oropharynx in adults. Emery Med Clin North Am 1985; 3: 143-60
23. Yarington CT. Sinusitis as an emergency. Otolaryngol Clin North Am 1979; 12: 447-54
24. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992; 93: 271-6
25. Brodie DP, Knight S, Cunningham K. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice. J Int Med Res 1989; 17: 547-51
26. Westphal JF. Cefuroxime axetil, a new cephalosporin for treating infections of the ORL field: clinical synthesis. Rev Laryngol Otol Rhinol (Bord) 1990; 111: 503-5
27. Sydnor A, Gwaltney JM, Cocchetto DM, et al. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1989; 115: 1430-3
28. Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1993; 45: 295-317
29. Barriere SL. Pharmacology and pharmacokinetics of cefprozil. Clin Infect Dis 1992; 14 Suppl. 2: S184-8
30. Van den Wijngaart W, Verbrugh H, Theopold HM, et al. A non-comparative study of cefprozil at two dose levels in the treatment of acute uncomplicated bacterial sinusitis. Clin Ther 1992; 14: 306-13
31. Russell MD, Nolen T, Allen JM, et al. Cefprozil versus amoxicillin/clavulanate in the treatment of acute, uncomplicated maxillary sinusitis in adults. Infect Med 1997; 14 Suppl. A: 43-50
32. Adelgrass J, Bundy JM, The Bacterial Sinusitis Study Group. Comparison of cefprozil and amoxicillin/clavulanate in the treatment of adults with acute bacterial sinusitis [abstract LM37]. Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology. San Francisco: September 1995
33. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77: 795-800
34. Makuch R, Simon RM. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep 1978; 62: 1037-40
35. Williams Jr JW, Simel DL, Roberts L, et al. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Int Med 1992; 117: 705-10
36. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol (Stockh) 1988; 105: 343-9
37. Axelsson A, Chidekel N, Grebelius N, et al. Treatment of acute maxillary sinusitis. A comparison of four different methods. Acta Otolaryngol 1970; 70: 71-6
38. Lindbæk M. Hjortdahl P, Johnsen UL-H. Randomised, double-blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996; 313: 325-9
39. van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, et al. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997; 349: 683-7
40. Willet LR, Carson JL, Williams Jr JW. Current diagnosis and management of sinusitis. J Gen Intern Med 1994; 9: 38-45
41. Axelsson A, Runze U. Symptoms and signs of acute maxillary sinusitis. ORL J Otorhinolaryngol Relat Spec 1976; 38: 298-308
42. Williams JW, Roberts Jr L, Distell B, et al. Diagnosing sinusitis by x-ray: is a single waters view adequate? J Gen Intern Med 1992; 7: 481-5
43. Lindbæk M, Johnsen UL-H, Kaastad E, et al. CT findings in general practice patients with suspected sinusitis. Acta Radiol 1996; 37: 708-13
44. Kennedy DW. Medical management of sinusitis: educational goals and management guidelines. Ann Otol Rhinol Laryngol 1995; 104 Suppl. 167: 22-30
45. Zinreich SJ. Paranasal sinus imaging. Otol Head Neck Surg 1990; 103 Suppl. Part 2: 863-9
46. McAllister WH, Lusk RP, Muntz HR. Comparison of plain radiographs and coronal CT scans in infants and children with recurrent sinusitis. Am J Roentgenol 1989; 153: 1259-64
47. Ceftin (cefuroxime axetil) Product Monograph, Compendium of Pharmaceuticals and Specialties, 32nd edition, 1997, pp. 261-2. Canadian Pharmaceutical Association, Ottawa, Ontario, Canada